News

Investors Alert: Action Required for Stellantis Case by Deadline

Investors Alert: Action Required for Stellantis Case by Deadline

Important Reminder for Stellantis Investors

It is crucial for investors in Stellantis N.V. to stay updated on a significant deadline. Glancy Prongay & Murray LLP is here to remind you that if you purchased or acquired securities of Stellantis during the Class Period, which spans certain dates in 2024, you have until October 15, 2024, to take necessary action.

Details of the Class Action Lawsuit

This class action lawsuit has been initiated on behalf of investors who bought Stellantis securities between February 15, 2024, and July 24, 2024. The deadline for filing a lead plaintiff motion is drawing near, and it is important for affected investors to be represented.

How to Participate in the Lawsuit

If you experienced a loss due to your investment in Stellantis, there are options available to recover your losses. Investors wishing to learn more about their rights are encouraged to reach out to Glancy Prongay & Murray LLP for assistance.

Concerns Raised in Financial Disclosures

On July 25, 2024, Stellantis released its semi-annual financial report for the initial half of 2024. The report indicated that the company had failed to meet the consensus estimates, leading to concerns regarding its future performance and financial stability. The report revealed a disappointing near-term outlook that significantly impacted investor confidence.

Impact of Financial Results on Stock Performance

The disappointing financial disclosures led to a sharp decline in Stellantis' stock value, with the price dropping by $1.94, which is a notable 9.9% decrease over two days. On July 26, 2024, Stellantis shares closed at $17.66 per share, raising alarms among investors.

Allegations in the Class Action Complaint

The class action complaint asserts that throughout the Class Period, Stellantis and its executives made materially false or misleading statements, while failing to disclose important facts about the company’s operational challenges. Investors were unaware of significant issues such as revenue shortfalls and unsuccessful business expansions, which were not adequately communicated to them.

Investors’ Rights and Actions

If you were a part of the class of investors who acquired Stellantis securities during the defined periods, you are encouraged to act swiftly. Appointments as a lead plaintiff can be requested through the court before the specified deadline. Those who choose not to take action at this juncture can still maintain their status as a member of the class.

Stay Informed and Connected

Investors seeking ongoing updates and information about the Stellantis case can connect with Glancy Prongay & Murray LLP through various platforms. Keeping in touch can help ensure you are aware of any significant developments pertaining to the lawsuit.

Frequently Asked Questions

1. What is the deadline for the Stellantis class action lawsuit?

The deadline for filing a lead plaintiff motion in the class action lawsuit is October 15, 2024.

2. What should I do if I invested in Stellantis during the Class Period?

If you purchased Stellantis securities during the Class Period, you should consult with a lawyer or contact Glancy Prongay & Murray LLP for guidance on potentially recovering your losses.

3. How did Stellantis' financial report impact its stock?

The company’s financial report indicated that it recorded disappointing results, leading to a significant decline in stock value by nearly 10% over two trading days.

4. What are the main allegations against Stellantis?

Allegations in the complaint assert that Stellantis made false statements and withheld critical information regarding its financial performance from investors.

5. How can I stay updated on the case?

Investors can follow Glancy Prongay & Murray LLP on various social media platforms for updates on the class action lawsuit.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 608

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 360

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Mako Hiraizumi Shines with Silver at Japan Triathlon

Updated Category News Views 23

A Triathlete with Grit and Ambition Mako Hiraizumi didn't just earn a silver medal at the 32nd Japan Triathlon National Championships; she set an example of perseverance and ambition. Rising a notch from her bronze finish last year, Hiraizumi's runner-up achievement at Tokyo's Odaiba Seaside Park is no small feat. Yet, she's not resting on her laurels. This athlete from...

Continue Reading
Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Updated Category News Views 149

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 124

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Tencent Cloud's Edge Platform Shines in New Gartner Report

Updated Category News Views 38

The Breakthrough in Edge Computing Everyone's talking about cloud this and cloud that, but Tencent Cloud is taking things a notch further with its EdgeOne platform. It's not just about storing your files in the sky; it's about having the fastest, most secure delivery possible. Gartner's latest report puts these guys right at the top in their Magic Quadrant for Edge...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 467

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 187

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Strathcona and Greenfire Set Sights on Major Merger

Updated Category News Views 101

Strathcona's Bold Move for Greenfire: A Game Changer? Just this week, Strathcona Resources Ltd. decided to make a big splash in the oil sands space by proposing to acquire Greenfire Resources Ltd. This isn’t your run-of-the-mill grab—it's a strategic tango expected to shift billions and reshape what we know about Canada’s oil sands territory. Unpicking the Deal...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 481

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading

Top 5 Most Recently Viewed Articles

Homebuyers Benefit as Mortgage Rates Hit New Lows

Updated Category News Views 110

Mortgage Rates See a Significant Drop Recent data shows that mortgage rates have fallen to their lowest point in more than 18 months. This presents a prime opportunity for homebuyers who might be thinking about refinancing their current loans. The drop in rates can be linked to various market dynamics, which has led to a noticeable spike in refinancing activity. Current...

Continue Reading
Cross River Bank Launches Innovative FDIC Sweep Service

Updated Category News Views 195

Introducing Cross River's Automated Sweep Feature Cross River Bank, a pioneering technology infrastructure provider known for its innovative embedded financial solutions, has recently unveiled its automated sweep feature leveraging the IntraFi Cash Service. This groundbreaking service allows Cross River's Banking-as-a-Service (BaaS) clients to access enhanced FDIC...

Continue Reading
Understanding P/E Ratio and Its Importance for PNC Investors

Updated Category News Views 198

Understanding the P/E Ratio for PNC Financial Services Group In today’s trading session, PNC Financial Services Group’s stock is valued at $187.43, reflecting a slight increase of 0.87%. Looking at the broader picture, the stock of PNC Financial Services Group Inc. has risen by an impressive 4.19% over the past month and a remarkable 63.74% in the past year. These...

Continue Reading
Grace Therapeutics Sees Positive Outcomes and Business Growth

Updated Category News Views 224

Grace Therapeutics Reports Promising Progress and Financial Update Grace Therapeutics, Inc. (NASDAQ: GRCE), a biopharmaceutical company dedicated to advancing treatment solutions, has just shared significant news regarding its fiscal operations and pivotal clinical advancements. The company focuses on developing GTx-104, a promising injectable formulation of nimodipine...

Continue Reading
Jordan G. Welch's Worship Culture Tour: A Transformative Experience

Updated Category News Views 643

Jordan G. Welch's Worship Culture Tour Unleashes New Dimensions in Worship The Worship Culture Tour is set to launch with a vibrant focus on creating an immersive worship experience that extends beyond traditional confines. This exciting two-day event will guide participants through a journey of spiritual growth across multiple cities, inviting people from all walks of...

Continue Reading